Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 4AbbVie Inc
03 8Orion Corporation
04 1Strides Pharma Science
05 1ANGENERICO SpA
06 1Abon Pharmaceuticals
07 2Amneal Pharmaceuticals
08 1Apotex Inc
09 1Bahrain Pharma
10 1Chartwell Pharmaceuticals llc
11 1Cosette Pharma
12 2DOC Generici
13 1Genchain Biotech
14 1Hanlim Pharmaceuticals Inc
15 1Hikma Pharmaceuticals
16 1Kolmar Korea Co., Ltd.
17 3LABORATORI BALDACCI SpA
18 2Laboratori Baldacci
19 6Lisapharma Spa
20 1Novell Pharmaceutical Laboratories
21 1Opes Health Care
22 1PD PARTNERS
23 1Padagis
24 1Paranova Pharmaceuticals Ab
25 1Pharmascience Inc.
26 2S.F.GROUP Srl
27 2SCHARPER SpA
28 2SF Group
29 2Scharper
30 1Sofar Spa
31 1Solfran Laboratories
32 1Solitaire Pharmacia
33 2Teva Pharmaceutical Industries
34 1Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories Sa
35 1Vaishali Pharma Ltd
36 1Viatris
37 1Vista Pharmaceuticals
38 1Zydus Lifesciences
01 2Antic-calc Tablet
02 1Chewable Tablets
03 3Gel
04 3Granules For Oral Suspension
05 1Ml
06 1Oral Powder
07 4Oral Suspension
08 2Potion, suspension
09 3SUSPENSION
10 10SUSPENSION;ORAL
11 2Sachet
12 1Sachets
13 4Sucralfate 1.000Mg 40 Combined Oral Use
14 8Sucralfate 2.000Mg 30 Joined' Oral Use
15 1Sucralfate 20% 200Ml Oral Use
16 3Suspension
17 4TABLET
18 5TABLET;ORAL
19 6Tablet
20 2Tablets
01 4Approved
02 1DISCN
03 2Deregistered
04 4Generic
05 5Prescription
06 14RX
07 36Blank
01 2ANTEPSIN
02 1APO-SUCRALFATE - TAB 1G
03 1Almiso Tablet
04 5Andapsin
05 7Antepsin
06 2CARAFATE
07 2DEGASTRIL
08 2Degastril
09 1PMS-SUCRALFATE
10 1Peptonorm
11 1Peptovell
12 13SUCRALFATE
13 1SUCRALFATE DOC GENERIC
14 2SUCRALFIN
15 2SUCRAMAL
16 1SUCRAMED
17 1SUCRATES
18 1SULCRATE
19 1SULCRATE SUSPENSION PLUS
20 2Skincol
21 2Sucralfate
22 2Sucralfin
23 2Sucramal
24 1Sucrate
25 2Sucrate Gel
26 1Sucroril
27 1Sufad
28 1TEVA-SUCRALFATE
29 1Ulivotina
30 4Blank
01 1Bahrain
02 5Canada
03 1China
04 3India
05 1Indonesia
06 27Italy
07 1Mexico
08 4Norway
09 2South Korea
10 6Sweden
11 15USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Sucralfin
Dosage Form : Sucralfate 1.000Mg 40 Combined Oral Use
Dosage Strength : 40 CPR 1 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : CARAFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1982-01-01
Application Number : 18333
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Antic-calc Tablet
Dosage Strength : 1 g
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2024-05-21
Application Number : 216474
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Sucralfin
Dosage Form : Sucralfate 2.000Mg 30 Joined' Oral Use
Dosage Strength : os grat 30 bust 2 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : SUCRALFIN
Dosage Form : Sachets
Dosage Strength : 2g
Packaging : 30 UNITS 2000 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : SUCRALFIN
Dosage Form : Tablet
Dosage Strength : 1g
Packaging : 40 UNITS 1000 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : CARAFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 1993-12-16
Application Number : 19183
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SULCRATE
Dosage Form : TABLET
Dosage Strength : 1G
Packaging :
Approval Date :
Application Number : 2100622
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SULCRATE SUSPENSION PLUS
Dosage Form : SUSPENSION
Dosage Strength : 1G/5ML
Packaging :
Approval Date :
Application Number : 2103567
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Antic-calc Tablet
Dosage Strength : 1 g
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Potion, suspension
Dosage Strength : 200 mg/ml
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Potion, suspension
Dosage Strength : 200 mg/ml
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Andapsin
Dosage Form : Tablet
Dosage Strength : 1g
Packaging :
Approval Date : 11/11/1983
Application Number : 19831111000065
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Andapsin
Dosage Form : Oral Suspension
Dosage Strength :
Packaging :
Approval Date : 08/01/1988
Application Number : 19880108000014
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Andapsin
Dosage Form : Oral Suspension
Dosage Strength : 200mg/ml
Packaging :
Approval Date : 12/12/1986
Application Number : 19861212000077
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Andapsin
Dosage Form : Oral Suspension
Dosage Strength : 2g/10ml
Packaging :
Approval Date : 26/07/1989
Application Number : 19890726000013
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2019-12-02
Application Number : 209356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1998-06-08
Application Number : 74415
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1996-03-29
Application Number : 70848
Regulatory Info : RX
Registration Country : USA
